TORNTPHARMTorrent Pharmaceuticals Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹5,005.40
▲ 5.09%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,68,325.80
P/E77.87
P/B20.07
PEG—
ROE %16.99
ROCE %14.70
Debt / Equity0.85
EPS63.87
Revenue Growth %41.80
Profit Growth %-21.70
Dividend Yield %0.76
Promoter Holding %71.19
FII Holding %15.78
DII Holding %—
Beta0.14
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 78% | ₹5,005.40 | ₹4,695.10 | ₹5,320.30 | 1.01 |
| Bullish Engulfing | LONG | 52% | ₹5,005.40 | ₹4,695.10 | ₹5,626.00 | 2.00 |
BUYConviction 84%
Why buy
- • Revenue growth: 41.8% YoY
- • ROE: 17.0%
- • Debt/Equity: 0.85
- • RSI: 66
- • MACD: bullish
- • Price vs EMA21: above
- • Bullish Engulfing signal (setup quality 52%)
- • Pullback to 21-EMA signal (setup quality 78%)
Bull case
- • Revenue growth: 41.8% YoY
- • ROE: 17.0%
- • Debt/Equity: 0.85
- • RSI: 66
Bear case
- • Profit growth: -21.7% YoY
- • Valuation vs sector: P/E 77.9 vs sector 38.6
Key risks
- • Profit growth: -21.7% YoY
- • Valuation vs sector: P/E 77.9 vs sector 38.6
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹5,005.40
Stop Loss
₹4,654.94
risk 7%
Target 1 (1.5R)
₹5,531.09
+10.5%
Target 2 (3R)
₹6,056.78
+21.0%
Support (20d)
₹4,460.10
Resistance (52w)
₹5,085.80
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹350.46/share
ATR (volatility)
₹140.18
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹140.18). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
54
Technical
81
Momentum
96
Risk (safety)
85